Clinical trial

Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes

NCT00331604

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention inhaled human insulin Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record insulin detemir Normalized identity: insulin detemirView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention insulin aspart Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-08-31

PhasePHASE3

Conditions

Diabetesverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

inhaled human insulinDRUG

insulin detemirDRUG · verified · RxNorm: insulin detemir

insulin aspartDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

TaipeiTaiwan2 HamburgGermany2 RomaItaly2 SingaporeSingapore2 DresdenGermany2 MilanItaly1 ToulouseFrance1 SevilleSpain1 StrasbourgFrance1 São PauloBrazil1 TaichungTaiwan1 JerusalemIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00331604 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.